蒙药额尔敦-乌日勒治疗缺血性卒中(萨病)恢复期的临床疗效

Clinical observation of Mongolia medicine Erdun wurile in the treatment of ischemic stroke at recovery stage

目的:观察蒙药额尔敦-乌日勒治疗缺血性卒中恢复期的临床效果。方法:将72例缺血性卒中恢复期患者按随机数表法分为治疗组和对照组,各36例。对照组给予西医常规(抗血小板聚集、降脂)联合康复训练治疗,治疗组在对照组基础上加用蒙药额尔敦-乌日勒治疗。治疗2个疗程,观察治疗前后两组蒙医证候积分、QLI评分和FIM评分,比较治疗效果。结果:经过治疗,两组蒙医证候积分、QLI评分和FIM评分均较治疗前提高,治疗组优于对照组。治疗组总有效率为88.89%(32/36),对照组总有效率为75.00%(27/36),治疗组与对照组相比差异有统计学意义(P<0.05)。结论:蒙药额尔敦-乌日勒治疗缺血性卒中恢复期疗效肯定,值得进一步研究。

Objective:To observe the effect of Mongolia medicine Erdun wurile on ischemic stroke recovery.Methods:72 patients with ischemic stroke in convalescent stage were randomly divided into treatment group and control group.The control group was given routine western medicine(antiplatelet aggregation,lipid-lowering)combined with rehabilitation training.The treatment group was treated with Mongolia medicine Erdun wurile on the basis of the control group.QLI score and FIM score were observed before and after treatment The therapeutic effects of two different methods on ischemic stroke patients at recovery stage were compared.Results:After treatment,QLI score and FIM score were improved compared with before treatment,and the curative effect of the treatment group was better than that of the control group.The total effective rate was 93.86%in the treatment group and 83.52%in the control group.There was statistical significance between the treatment group and the control group(P<0.05).Conclusion:Mongolia medicine Erdun wurile is effective in the treatment of ischemic stroke in convalescent stage,which is worthy of further study.